Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2023
Cash flows from operating activities:              
Net loss $ (1,445,000) $ (2,139,000) $ (3,749,000) $ (4,130,000) $ (5,265,000) $ (12,956,000)  
Adjustments to reconcile net loss to net cash used in operating activities              
Depreciation         647,000 412,000  
Stock-based compensation 235,000   152,000   539,000 601,000  
Amortization of debt issuance costs         445,000  
Noncash lease expense         370,000 324,000  
Allowance for inventory reserve         214,000 109,000  
Changes in operating assets and liabilities:              
Accounts receivable         (1,244,000) (3,411,000)  
Inventories         (4,911,000) (10,530,000)  
Other current assets         11,000 (118,000)  
Accounts payable         4,182,000 6,186,000  
Accrued expenses         395,000 (441,000)  
Accrued interest         2,000  
Office lease payable         (379,000) (322,000)  
Deferred revenue         (163,000) 289,000  
Customer deposits         (40,000) 519,000  
Net cash used in operating activities         (5,197,000) (19,338,000) $ (23,900,000)
Cash flows from investing activities              
Purchases of equipment         (753,000) (644,000)  
Proceeds from sale of fixed assets         8,000  
Net cash used in investing activities         (745,000) (644,000)  
Cash flows from financing activities:              
Proceeds from issuance of common stock in registered direct offering, net of offering costs         13,971,000  
Proceeds from issuance of common stock in public offering, net of offering costs         697,000 1,602,000  
Proceeds from revolving line of credit         48,800,000 3,500,000  
Payment of revolving line of credit         (43,198,000)  
Payment of financed leases         (52,000)  
Net cash provided by financing activities         6,247,000 19,073,000  
Net change in cash         305,000 (909,000)  
Cash, beginning of period   $ 485,000   $ 4,713,000 485,000 4,713,000 $ 485,000
Cash, end of period $ 790,000   $ 3,804,000   790,000 3,804,000  
Supplemental Disclosures of Non-Cash Investing and Financing Activities:              
Initial right of use asset recognition         855,000  
Common stock issued for vested RSUs         114,000 10,000  
Supplemental cash flow information:              
Interest paid         $ 524,000 $ 86,000